porcin
epidem
diarrhea
ped
highli
contagi
diseas
caus
wateri
diarrhea
vomit
electrolyt
imbal
dehydr
piglet
morbid
mortal
rate
highli
correl
age
immun
statu
suscept
piglet
caus
agent
ped
singl
strand
envelop
rna
viru
name
porcin
epidem
diarrhea
viru
pedv
belong
genera
alphacoronaviru
famili
coronavirida
order
nidoviral
pedv
approxim
pair
genom
includ
seven
open
read
frame
encod
nonstructur
structur
protein
four
major
structur
protein
envelop
e
membran
spike
nucleocapsid
n
n
protein
produc
earli
infect
stage
abund
protein
throughout
entir
viral
propag
process
protein
anchor
envelop
virion
form
small
amount
e
protein
wherea
protein
protrud
homolog
trimer
shape
crownlik
project
viral
surfac
among
structur
protein
protein
superfici
glycoprotein
respons
establish
infect
induc
neutral
antibodi
protein
divid
region
amino
acid
aa
region
aa
gener
region
subdivid
five
structur
domain
domin
viralhost
recognit
receptor
bind
wherea
region
trigger
viral
fusion
intern
addit
three
neutral
epitop
spike
protein
pedv
report
includ
k
equival
epitop
coe
epitop
aa
epitop
aa
epitop
aa
recent
domain
well
cterminu
demonstr
particip
viru
neutral
function
import
protein
pedv
make
key
target
vaccin
develop
immun
statu
evalu
ped
first
report
europ
asia
earli
follow
thirti
year
report
emerg
sever
countri
recent
genotyp
pedv
high
virul
found
affect
asia
america
result
signific
econom
loss
swine
industri
especi
china
korea
japan
taiwan
us
canada
mexico
mortal
rate
seroneg
neonat
piglet
high
virul
ped
infect
reach
current
diseas
still
circul
sever
countri
therefor
evalu
pedvspecif
immun
respons
piglet
sow
essenti
evalu
allow
us
determin
efficaci
immun
predict
trend
immun
statu
field
creat
strategi
prevent
control
ped
current
sever
enzymelink
immunosorb
assay
elisa
establish
commerci
detect
system
igg
mucos
iga
pedv
commerci
avail
elisa
kit
pedv
mainli
base
n
protein
pedv
n
protein
domin
protein
massiv
produc
infect
procedur
abl
provok
strong
immun
respons
howev
previou
studi
reveal
whole
viru
n
protein
proteinbas
elisa
may
detect
crossreact
antibodi
swine
coronavirus
hand
sever
pedv
sbase
elisa
develop
confirm
crossreact
porcin
coronavirus
result
suggest
sbase
elisa
may
suitabl
detect
pedvspecif
antibodi
mammalian
express
system
uniqu
abil
produc
protein
complex
conform
structur
contain
appropri
posttransl
modif
precis
fold
appropri
modif
target
antigen
key
vaccin
serolog
assay
develop
date
one
aa
base
elisa
develop
mammalian
protein
express
system
earlier
appli
human
embryon
kidney
hek
cell
deriv
pedvpintung
pt
trimer
fulllength
proteinbas
elisa
detect
antibodi
homolog
strain
howev
differ
perform
trimer
fulllength
sbase
pedv
elisa
contain
epitop
span
complet
viral
protein
truncat
sbase
pedv
elisa
contain
partial
epitop
protein
detect
antibodi
heterolog
histor
pedv
strain
unknown
addit
sensit
specif
cost
effect
also
import
concern
develop
elisa
kit
present
studi
first
determin
express
level
panel
differ
truncat
protein
gener
previou
studi
truncat
protein
compris
residu
aa
protein
select
show
highest
protein
yield
sensit
specif
interrat
agreement
pedv
trimer
fulllength
protein
indirect
elisa
compar
commerci
nbase
indirect
elisa
kit
use
panel
pedv
hyperimmun
serum
target
homolog
heterolog
strain
pedv
order
select
truncat
protein
highest
express
level
hek
cell
develop
costeffect
elisa
kit
yield
differ
truncat
pedv
protein
compar
total
amount
fulllength
protein
purifi
ml
cultur
supernat
compar
total
amount
purifi
protein
respect
along
highpur
fulllength
protein
protein
also
chosen
candid
develop
elisa
due
superior
protein
express
level
compar
truncat
protein
cell
puriti
qualiti
protein
confirm
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
electrophoresi
page
addit
file
figur
panel
pedv
neg
serum
sampl
select
wellmanag
pedv
exposur
histori
convent
spf
farm
panel
posit
serum
sampl
select
convent
spf
pig
pedv
infect
histori
either
experiment
pedvpt
inocul
oral
feedback
use
intestin
homogen
deriv
pedvinfect
piglet
antipedv
titer
serum
sampl
character
either
immunofluoresc
assay
ifa
immunocytochem
stain
icc
repres
immunostain
imag
shown
fig
sampl
exhibit
high
stain
background
dilut
immunostain
titer
serum
sampl
dilut
determin
twofold
serial
dilut
studi
immunostain
titer
neg
sampl
includ
cn
pig
spfn
pig
thu
confirm
neg
serum
sampl
immunostain
titer
posit
group
ci
pig
rang
includ
serum
sampl
serum
sampl
serum
sampl
serum
sampl
serum
sampl
immunostain
titer
fifteen
spfi
pig
consist
serum
titer
pig
vari
includ
serum
sampl
serum
sampl
serum
sampl
serum
sampl
serum
sampl
serum
sampl
posit
group
confirm
posit
immunostain
colostrum
spf
sow
titer
repres
detect
pedvspecif
iga
howev
colostrum
sampl
convent
sow
posit
includ
colostrum
colostrum
colostrum
colostrum
colostrum
accord
manufactur
guidelin
cutoff
valu
n
proteinbas
id
pedv
indirect
idvet
sampl
posit
ratio
sp
ratio
serum
sampl
must
consid
posit
shown
tabl
serum
sampl
randomli
pick
cn
pig
well
serum
sampl
spfn
pig
found
neg
screen
n
proteinbas
id
pedv
indirect
idvet
twentythre
serum
sampl
randomli
chosen
ci
pig
eight
twentythre
determin
posit
serum
sampl
neg
eleven
fourteen
serum
sampl
spfi
pig
posit
three
neg
hand
four
twentysix
serum
sampl
sowf
pig
posit
remain
twentytwo
serum
sampl
neg
use
result
immunostain
gold
standard
sensit
specif
n
proteinbas
id
pedv
indirect
idvet
respect
kappa
valu
icc
stain
n
proteinbas
id
pedv
indirect
idvet
repres
fair
agreement
distribut
result
n
proteinbas
elisa
immunostain
titer
present
fig
use
receiv
oper
characterist
roc
analysi
shown
fig
cutoff
valu
fulllength
sbase
elisa
determin
obtain
sensit
specif
summar
tabl
start
cutoff
valu
fortyeight
fifti
serum
sampl
ci
pig
fourteen
serum
sampl
spfi
pig
twentysix
serum
sampl
sowf
pig
found
posit
two
fifti
serum
sampl
ci
pig
fals
neg
result
eleven
one
hundr
ninetynin
serum
sampl
cn
group
fals
posit
result
remain
serum
sampl
cn
group
serum
sampl
spfn
group
neg
kappa
valu
interrat
agreement
fulllength
sbase
elisa
immunostain
almost
perfect
distribut
immunostain
titer
result
fulllength
sbase
elisa
distribut
shown
fig
use
roc
analysi
cutoff
valu
elisa
determin
obtain
sensit
specif
fig
shown
tabl
fig
except
one
serum
ci
pig
ci
spfi
sowf
sampl
posit
cutoff
valu
except
two
serum
sampl
cn
group
posit
serum
sampl
cn
group
serum
sampl
spfn
group
neg
kappa
valu
elisa
cutoff
valu
mean
result
elisa
almost
perfect
agreement
immunostain
result
fig
figur
b
show
distribut
result
assay
kappa
valu
commerci
n
proteinbas
elisa
fulllength
sbase
elisa
elisa
respect
mean
assay
show
fair
agreement
contrast
agreement
fulllength
sbase
elisa
elisa
almost
perfect
kappa
valu
determin
perform
sbase
elisa
detect
colostrum
pedv
specif
iga
twentythre
colostrum
sampl
collect
pedv
seroposit
convent
sow
ped
outbreak
feedback
histori
month
posit
control
five
colostrum
sampl
collect
pedv
seroneg
spf
sow
neg
control
pedv
specif
iga
titer
determin
use
icc
assay
rang
posit
neg
colostrum
sampl
respect
shown
fig
sp
ratio
colostrum
iga
pedv
seroneg
spf
sow
approxim
fulllength
sbase
elisa
importantli
sp
ratio
colostrum
iga
feedback
convent
sow
rang
fulllength
sbase
elisa
respect
higher
sp
ratio
pedv
seroneg
spf
sow
confirm
fulllength
elisa
could
use
detect
antibodi
homolog
pedv
evalu
whether
fulllength
elisa
abl
detect
antibodi
target
heterolog
histor
pedv
fulllength
sequenc
gene
taiwan
histor
strain
synthes
codon
optim
cell
protein
strain
success
express
character
via
immunocytochem
icc
stain
tag
antibodi
fig
b
protein
purif
molecular
weight
pedv
protein
identifi
approxim
kda
western
blot
fig
follow
three
round
immun
immunostain
titer
serum
deriv
proteinimmun
pig
determin
sp
ratio
serum
fulllength
sbase
elisa
elisa
respect
sinc
cutoff
valu
sbase
elisa
elisa
respect
result
interpret
posit
two
pedv
proteinbas
elisa
fulllength
sbase
truncat
elisa
develop
studi
standard
use
comparison
studi
immunostain
pedvpt
infect
vero
cell
base
result
show
perform
elisa
detect
pedv
specif
igg
better
fulllength
sbase
elisa
commerci
pedv
nbase
elisa
furthermor
also
demonstr
pedv
proteinbas
elisa
abl
detect
iga
antibodi
colostrum
pedv
specif
serum
igg
excel
perform
high
protein
yield
elisa
afford
effici
choic
develop
serolog
assay
pedv
sever
elisa
detect
pedvspecif
antibodi
establish
previou
studi
major
coat
antigen
includ
n
protein
express
prokaryot
protein
express
system
achiev
high
yield
protein
product
howev
protein
express
use
prokaryot
express
system
may
lack
appropri
protein
fold
complex
posttransl
modif
glycosyl
could
lead
reduct
sensit
specif
elisa
kit
studi
mammalian
express
system
use
express
coat
antigen
protein
develop
pedv
elisa
protein
pedv
key
target
viru
neutral
vaccin
develop
contain
sever
neutral
epitop
may
import
indic
evalu
immun
pedv
protein
coronaviru
demonstr
display
complex
structur
contain
least
predict
nglycosyl
site
mammalian
protein
express
system
allow
proper
format
complex
multidimension
structur
posttransl
modif
therebi
gener
antigen
attain
high
sensit
elisa
protein
pedv
trimer
protein
similar
coronavirus
trimer
form
protein
may
contain
conform
epitop
monomer
protein
therefor
full
length
trimer
spike
protein
contain
epitop
consid
import
target
develop
elisa
howev
larg
molecular
size
fulllength
protein
present
challeng
larg
scale
protein
express
product
difficulti
mani
studi
prefer
use
instead
fulllength
conduct
vaccin
serolog
assay
develop
high
sensit
specif
elisa
develop
use
protein
pedv
produc
freestyl
cell
suggest
truncat
protein
might
also
good
candid
develop
pedv
sbase
elisa
howev
perform
elisa
never
compar
fulllength
pedv
sbase
elisa
base
comparison
protein
yield
differ
truncat
proteinexpress
stabl
cell
elisa
success
develop
interestingli
fulllength
sbase
elisa
superior
term
abil
detect
pedvspecif
antibodi
compar
truncat
elisa
present
studi
protein
prepar
supernat
stabl
cell
line
reduc
expens
transfect
express
furthermor
express
stabl
cell
line
select
base
superior
protein
express
quantiti
cultur
supernat
other
elisa
applic
approxim
protein
use
prepar
plate
elisa
suggest
ml
cultur
supernat
could
use
prepar
two
elisa
plate
excel
perform
truncat
elisa
highest
protein
express
level
indic
would
good
antigen
pedv
elisa
find
similar
previou
report
protein
found
ideal
antigen
develop
elisa
higher
sensit
better
specif
n
proteinbas
elisa
fulllength
sbase
elisa
much
better
sensit
commerci
nbase
elisa
kit
sbase
elisa
use
studi
use
spf
pig
convent
pig
sow
wherea
commerci
nbase
elisa
perform
well
spf
pig
rel
low
background
stronger
immun
respons
sbase
elisa
use
detect
immun
respons
immun
statu
popul
indispens
tool
evalu
efficaci
pedv
vaccin
current
sever
pedv
strain
circul
north
america
asia
therefor
establish
serolog
assay
abl
detect
pedv
antibodi
import
order
evalu
immun
statu
swine
popul
sinc
clinic
confirm
serum
pedv
avail
lab
fulllength
pedv
protein
deriv
histor
taiwan
strain
gener
use
antigen
immun
pig
gener
hyperimmun
serum
protein
pedv
strain
protein
particular
demonstr
rel
high
heterogen
genotyp
cluster
ident
amino
acid
rang
compar
protein
amino
acid
sequenc
fulllength
pedvpt
strain
share
approxim
ident
pedv
protein
respect
demonstr
elisa
deriv
pedvpt
strain
show
compar
perform
fulllength
sbase
elisa
detect
homolog
heterolog
pedvspecif
antibodi
studi
fulllength
sbase
elisa
perform
well
test
serum
sampl
differ
sourc
well
colostrum
sampl
sow
moreov
two
elisa
suitabl
use
detect
pedv
antibodi
take
account
perform
cost
elisa
sensit
specif
close
high
protein
yield
best
choic
develop
pedv
elisa
procedur
involv
anim
approv
permit
institut
anim
care
use
committe
iacuc
nation
taiwan
univers
ntu
taiwan
republ
china
carri
regul
iacuc
protocol
ntu
approv
number
total
serum
sampl
use
studi
neg
control
sampl
high
manag
pedv
exposur
histori
farm
sampl
convent
farm
sampl
spf
farm
posit
control
sampl
pig
infect
histori
sampl
pedvpt
challeng
convent
postwean
pig
sampl
pedvpt
challeng
spf
pig
sampl
sow
receiv
pedv
strain
feedback
henc
serum
sampl
pig
use
studi
divid
five
group
convent
pedv
cn
pig
experiment
pedvpt
inocul
convent
ci
pig
specif
pathogenfre
pedv
spfn
pig
experiment
pedvpt
inocul
spf
spfi
pig
pedvfeedback
sow
sowf
tabl
pedvpt
experiment
challeng
anim
oral
receiv
pedvpt
passag
serum
sampl
anim
collect
two
week
pedv
challeng
postwean
spf
pig
purchas
anim
technolog
institut
taiwan
atit
detect
pedv
specif
colostrum
iga
twentythre
colostrum
sampl
pedv
seroposit
convent
sow
ped
outbreak
feedback
histori
previou
month
colostrum
sampl
pedv
seroneg
spf
sow
use
pedvpt
strain
genbank
prepar
previous
describ
passag
pedvpt
use
antigen
immunostain
present
studi
brief
prepar
virusinfect
vero
cell
plate
visibl
cytopath
effect
cpe
ie
presenc
syncyti
cell
vero
cell
seed
onto
cultur
plate
thermo
fisher
scientif
waltham
usa
confluenc
h
cell
wash
pb
gibco
gaithersburg
md
usa
three
time
inocul
dilut
postinocul
pi
medium
contain
dmem
gibco
tryptos
phosphat
broth
sigma
st
loui
mo
usa
yeast
extract
acumedia
lans
ca
usa
trypsin
gibco
h
incub
cpe
observ
supernat
discard
pedvinfect
vero
cell
area
cover
cytopath
effect
cpe
fix
aceton
sigma
min
remov
aceton
airdri
h
plate
store
use
character
determin
pedvspecif
antibodi
titer
serum
colostrum
sampl
use
studi
immunostain
pedvinfect
vero
cell
icc
ifa
use
gold
standard
determin
immunostain
titer
sampl
serum
colostrum
serial
dilut
pb
gibco
volum
sampl
ad
plate
pedvinfect
vero
cell
prepar
previous
incub
h
room
temperatur
gentl
shake
wash
six
time
pb
gibco
next
goatantiswin
igg
secondari
antibodi
conjug
horseradish
peroxidas
hrp
kpl
seracar
usa
conjug
fluoresc
jackson
laboratori
usa
dilut
ad
well
incub
h
wash
six
time
pb
gibco
stain
visual
use
envisiondab
system
dako
santa
clara
ca
usa
observ
fluoresc
microscop
standard
color
procedur
plate
includ
posit
serum
dilut
posit
control
color
develop
stop
posit
control
color
color
develop
evalu
use
invert
lightfluoresc
microscop
avoid
possibl
nonspecif
signal
immunostain
signal
consid
posit
appear
syncyti
vero
cell
show
cpe
signal
appear
morpholog
normal
vero
cell
cpe
cell
result
consid
neg
fulllength
truncat
protein
pedvpt
includ
protein
sequenc
contain
aa
construct
express
cell
previous
describ
pedv
sexpress
cell
select
use
geneticin
gibco
contain
dmem
gibco
two
week
becam
stabl
protein
express
cell
line
compar
protein
yield
fulllength
truncat
protein
pedvpt
express
hek
cell
protein
purifi
ml
freestyl
express
medium
gibco
elut
ml
buffer
previous
describ
concentr
protein
measur
use
bca
protein
assay
kit
thermo
fisher
scientif
accord
manufactur
protocol
determin
puriti
qualiti
truncat
protein
use
elisa
truncat
protein
first
denatur
ld
sampl
buffer
thermo
fisher
scientif
contain
reduc
agent
thermo
fisher
scientif
boil
min
denatur
protein
separ
sdspage
detect
coomassi
blue
biorad
protein
dye
commerci
n
proteinbas
pedv
elisa
kit
id
pedv
indirect
idvet
montpelli
franc
use
studi
accord
manufactur
instruct
briefli
serum
ad
well
contain
dilut
buffer
idvet
result
tenfold
dilut
incub
min
well
wash
three
time
wash
solut
idvet
conjug
dilut
dilut
buffer
idvet
ad
mixtur
incub
anoth
min
wash
three
time
substrat
idvet
ad
well
allow
react
color
min
stop
solut
idvet
use
stop
color
reaction
plate
read
nm
use
emax
plu
micropl
reader
molecular
devic
crawley
uk
per
manufactur
instruct
sp
ratio
interpret
neg
sp
ratio
posit
sp
ratio
recombin
protein
dilut
coat
buffer
kpl
seracar
usa
coat
nunc
maxisoap
plate
thermo
fisher
scientif
h
wash
six
time
wash
buffer
kpl
seracar
well
block
block
buffer
kpl
seracar
room
temperatur
h
serum
sampl
dilut
block
buffer
ad
per
well
wash
plate
incub
h
room
temperatur
wash
six
time
previous
describ
hrpconjug
goatantiswin
igg
antibodi
kpl
seracar
ad
well
dilut
plate
incub
h
room
temperatur
color
procedur
initi
appli
peroxidas
substrat
system
kpl
seracar
onto
wash
plate
color
step
stop
ad
stop
solut
kpl
seracar
signal
read
nm
use
emax
plu
micropl
reader
molecular
devic
elisa
assay
doubleposit
sampl
immunostain
pedvinfect
vero
cell
commerci
pedv
elisa
chosen
interexperiment
posit
control
similarli
doubleneg
serum
chosen
neg
control
studi
determin
cutoff
valu
differ
truncat
sbase
elisa
neg
serum
sampl
cn
spfn
group
posit
serum
sampl
ci
spfi
sowf
group
use
immunostain
pedvinfect
vero
cell
analyz
duplic
elisa
data
express
sp
ratio
optim
cutoff
valu
elisa
analyz
determin
roc
analysi
spss
statist
obtain
best
combin
sensit
specif
measur
interrat
agreement
differ
elisa
cohen
kappa
coeffici
valu
result
immunostain
commerci
pedvn
elisa
fulllength
sbase
elisa
elisa
calcul
compar
strength
agreement
consid
describ
kappa
valu
poor
slight
fair
moder
substanti
almost
perfect
repeat
fulllength
sbase
elisa
elisa
evalu
analyz
serum
sampl
duplic
obtain
mean
sp
ratio
sampl
evalu
whether
sbase
elisa
develop
present
studi
could
detect
pedv
specif
mucos
iga
colostrum
pedv
seroposit
neg
pig
use
five
colostrum
sampl
pedv
seroneg
spf
sow
colostrum
sampl
pedv
seroposit
convent
sow
preexpos
pedv
natur
infect
feedback
includ
studi
colostrum
centrifug
rpm
min
obtain
milk
serum
elisa
procedur
describ
follow
two
modif
milk
serum
dilut
use
primari
antibodi
antipig
iga
hrpconjug
antibodi
sigma
dilut
use
secondari
antibodi
readout
elisa
calcul
sp
ratio
determin
crossreact
pedvpt
sbase
elisa
pedv
first
necessari
produc
pedv
protein
order
obtain
porcin
pedv
hyperimmun
serum
pedv
use
studi
taiwan
histor
pedv
strain
genbank
gene
encod
protein
synthes
codonoptim
clone
vector
invitrogen
previous
describ
character
protein
taiwan
histor
strain
verifi
use
western
blot
previous
describ
postwean
convent
pedv
cn
pig
purchas
inject
intramuscularli
taiwan
histor
pedv
strain
genbank
protein
freund
adjuv
sigma
three
time
interv
serum
sampl
obtain
two
week
third
inject
serum
sampl
serial
dilut
icc
carri
infect
vero
cell
determin
titer
immunostain
final
serum
use
commerci
n
proteinbas
id
pedv
indirect
idvet
elisa
pedvpt
sbase
elisa
follow
procedur
describ
evalu
crossreact
elisa
